Artículos por temáticas

Neuroprotective effects of hesperidin, a plant flavanone, on rotenone-induced oxidative stress and apoptosis in a cellular model for Parkinson's disease.

Tamilselvam K, Braidy N, Manivasagam T, Essa MM, Prasad NR, Karthikeyan S, Thenmozhi AJ, Selvaraju S, Guillemin GJ.

Oxid Med Cell Longev. 2013;2013:102741. doi: 10.1155/2013/102741.

Measurement of LRRK2 and Ser910/935 phosphorylated LRRK2 in peripheral blood mononuclear cells from idiopathic Parkinson's disease patients.

Dzamko N, Chua G, Ranola M, Rowe DB, Halliday GM.

J Parkinsons Dis. 2013;3(2):145-52. doi: 10.3233/JPD-130174.

Why psychosis is frequently associated with Parkinson's disease?

Zhong J, Wu S, Zhao Y, Chen H, Zhao N, Zheng K, Zhao Z, Chen W, Wang B, Wu K.

Neural Regen Res. 2013 Sep 25;8(27):2548-56. doi: 10.3969/j.issn.1673-5374.2013.27.006.

Idiopathic Parkinson's disease phenotype related to C9ORF72 repeat expansions: contribution of the neuropsychological assessment.

Annan M, Beaufils É, Viola UC, Vourc'h P, Hommet C, Mondon K.

BMC Res Notes. 2013 Aug 29;6:343. doi: 10.1186/1756-0500-6-343.

A case of paranoid schizophrenia and severe antipsychotic-induced Parkinson's disorder treated with a combination of olanzapine and lurasidone.

Tcheremissine OV, Englert D.

Innov Clin Neurosci. 2013 Sep;10(9-10):10-1. No abstract available.

Effect of levodopa on both verbal and motor representations of action in Parkinson's disease: a fMRI study.

Péran P, Nemmi F, Méligne D, Cardebat D, Peppe A, Rascol O, Caltagirone C, Demonet JF, Sabatini U.

Brain Lang. 2013 Jun;125(3):324-9. doi: 10.1016/j.bandl.2012.06.001.

LRRK2 G2385R variant carriers of female Parkinson's disease are more susceptible to motor fluctuation.

Gao C, Pang H, Luo XG, Ren Y, Shang H, He ZY.

J Neurol. 2013 Nov;260(11):2884-9. doi: 10.1007/s00415-013-7086-9. Erratum in: J Neurol. 2014 Jan;261(1):250.

Falls related to accidental deactivation of deep brain stimulators in patients with Parkinson's disease living in long term care facilities.

Tousi B, Wilson K.

J Am Med Dir Assoc. 2013 Jan;14(1):58-9. doi: 10.1016/j.jamda.2012.08.011.

Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment.

Cannon JR, Geghman KD, Tapias V, Sew T, Dail MK, Li C, Greenamyre JT.

Exp Neurol. 2013 Feb;240:44-56. doi: 10.1016/j.expneurol.2012.11.007.

Prevalence and profile of Restless Legs Syndrome in Parkinson's disease and other neurodegenerative disorders: a case-control study.

Bhalsing K, Suresh K, Muthane UB, Pal PK.

Parkinsonism Relat Disord. 2013 Apr;19(4):426-30. doi: 10.1016/j.parkreldis.2012.12.005.

The benefits of exercise in Parkinson disease.

Rosenthal LS, Dorsey ER.

JAMA Neurol. 2013 Feb;70(2):156-7. doi: 10.1001/jamaneurol.2013.772. No abstract available.

200-300Hz movement modulated oscillations in the internal globus pallidus of patients with Parkinson's Disease.

Tsiokos C, Hu X, Pouratian N.

Neurobiol Dis. 2013 Jun;54:464-74. doi: 10.1016/j.nbd.2013.01.020.

Neurostimulation earlier for selected adults with Parkinson's disease.

[No authors listed]

BMJ. 2013 Feb 20;346:f1051. doi: 10.1136/bmj.f1051. No abstract available.

Influence of educational status on executive function and functional balance in individuals with Parkinson disease.

Souza Cde O, Voos MC, Francato DV, Chien HF, Barbosa ER.

Cogn Behav Neurol. 2013 Mar;26(1):6-13. doi: 10.1097/WNN.0b013e31828c5956.

Is there a need to redefine Parkinson's disease?

Mahlknecht P, Poewe W.

J Neural Transm (Vienna). 2013 Sep;120 Suppl 1:S9-17. doi: 10.1007/s00702-013-1038-5. Review.